Next-Generation Artificial Intelligence for Drug Repurposing: Integrating Machine Learning, Deep Learning, Multi-Omics, Knowledge Graphs, and Clinical Translation: A Review

Sushma N; Rachana SN; Aruna MV; sunil kumar busi; Gopinath E

doi:10.36948/ijfmr.2026.v08i04.85535

Next-Generation Artificial Intelligence for Drug Repurposing: Integrating Machine Learning, Deep Learning, Multi-Omics, Knowledge Graphs, and Clinical Translation: A Review

Author(s)	Ms. Sushma N, Ms. Rachana SN, Ms. Aruna MV, Dr. sunil kumar busi, Dr. Gopinath E
Country	India
Abstract	Drug repurposing has emerged as a promising strategy to accelerate drug discovery by identifying new therapeutic indications for existing approved or investigational drugs, thereby reducing development time, cost, and clinical risk compared with traditional de novo drug development. The rapid expansion of biomedical big data, together with advances in artificial intelligence (AI) and machine learning (ML), has transformed computational drug repurposing into a data-driven and highly efficient discipline. Conventional machine learning algorithms, including Support Vector Machines, Random Forests, and gradient boosting methods, have demonstrated significant utility in predicting drug-target and drug-disease associations. More recently, deep learning architectures such as Convolutional Neural Networks (CNNs), Recurrent Neural Networks (RNNs), Autoencoders, Transformer-based models, and Graph Neural Networks (GNNs) have enabled the integration of heterogeneous datasets, including chemical structures, transcriptomics, proteomics, metabolomics, pharmacogenomics, protein-protein interaction networks, and electronic health records, substantially improving prediction accuracy. This review provides a comprehensive overview of AI-driven drug repurposing, covering computational strategies, publicly available biomedical databases, feature representation methods, machine learning and deep learning algorithms, and their applications in cancer, infectious diseases, neurological disorders, cardiovascular diseases, and rare diseases. Furthermore, recent advances in knowledge graphs, explainable artificial intelligence (XAI), federated learning, foundation models, and large language models (LLMs) are discussed as emerging technologies capable of improving prediction reliability, interpretability, and clinical applicability. Current challenges, including data heterogeneity, limited external validation, algorithmic bias, model interpretability, and regulatory barriers, are critically evaluated. Finally, future perspectives focusing on multimodal multi-omics integration, digital twins, real-world evidence, and precision medicine are presented.
Keywords	Drug repurposing; Drug repositioning; Artificial intelligence; Machine learning; Deep learning; Graph neural networks; Multi-omics; Knowledge graphs; Explainable AI; Precision medicine.
Field	Medical / Pharmacy
Published In	Volume 8, Issue 4, July-August 2026
Published On	2026-08-14
DOI	https://doi.org/10.36948/ijfmr.2026.v08i04.85535

View / Download PDF File

About IJFMR Fees & Payment Current Issue Publication Archive	Submit Research Paper Track Submission Status Publication Guidelines Publication Ethics Peer Review & Plagiarism	Join as a Reviewer Editors & Reviewers Reviewer Referral Program Get Reviewer Membership Certi.	Website/Journal Policies Usage Policy Content Policies Privacy Policy

Contact Us		+91-9687-828-838	editor@ijfmr.com

International Journal For Multidisciplinary Research

A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal

Next-Generation Artificial Intelligence for Drug Repurposing: Integrating Machine Learning, Deep Learning, Multi-Omics, Knowledge Graphs, and Clinical Translation: A Review

Share this